{"task_id": "399f2ecfefc5d49f", "source": "Approach to Internal Medicine_ A Resource Book for Clinical Practice ( PDFDrive ).pdf (Part 131/464)", "text": "\n0.3\nDry tongue\n59%\n73%\n2.1\n0.6\n118\nUpper GI Bleed\n\n--- Page 140 ---\nINVESTIGATIONS\nBASIC\n\u0002\nLABS\nCBCD, lytes, urea, Cr, type/cross match,\nPTT, INR, AST, ALT, ALP, bilirubin, albumin, fecal\noccult blood\n\u0002\nIMAGING\nCXR, AXR\n\u0002\nGASTROSCOPY\nPROGNOSTIC ISSUES\nRISK STRATIFICATION FOR PEPTIC ULCER DISEASE\n\u0002\nCLINICAL ROCKALL\nSCORING\nage 60 79=1; age\n\u000580=2; heart rate >100 beats/min=1; systolic BP\n<100 mmHg=2; co existing illnesses (ischemic\nheart disease, HF, other major illness)=2; co exist\ning illnesses (renal failure, hepatic failure, meta\nstatic cancer)=3\n\u0002\nCOMPLETE ROCKALL SCORING\nin addition to clinical\nRockall score, add the following based on endo\nscopic findings: no lesion observed, Mallory Weiss\ntear=0; peptic ulcer, erosive disease, esophagi\ntis=1; cancer of upper GI tract=2; clean base\nulcer, flat pigmented spot=0; blood in upper GI\ntract, active bleeding, visible vessel, clot=2\n\u0002\nINTERPRETATION\nlow risk for bleeding or death=\nclinical Rockall score 0 or complete Rockall score \u00072\nRISK OF ULCER RE BLEED\n\u0002\nHIGH-RISK FEATURES\nactive spurting/oozing dur\ning endoscopy (90% chance), non bleeding visible\nvessel (50% chance), adherent clot (25 30%\nchance). If none of above factors and clinically\nnot severe bleed, very low chance of rebleed and\nmay consider discharging shortly after. Other fac\ntors include size and location of ulcer\n\u0002\nLOW-RISK FEATURES\nflat spot (10% chance), clean\nulcer base (3 5% chance)\nMANAGEMENT\nACUTE\nABC, O2, IV hydration (two large bore IV).\nTransfusion (especially if hematocrit <30%, plate\nlets <50\u0004109). NPO, consider NG tube. Hold\nMANAGEMENT (CONT\u2019D)\nantihypertensive and diuretic therapy. If prolonged\nPT/PTT, vitamin K 10 mg PO/IV (small risk of anaphy\nlaxis with IV administration) and/or FFP 2 4 U IV if\nrapid reversal required. If on heparin, protamine\ninfusion (1 mg antagonizes 100 U of heparin\nbeware of excessive protamine which can cause para\ndoxical coagulopathy). If suspect varices, octreotide\n50 mg IV bolus, then 25 50 mg/hour. If suspect ulcer,\npantoprazole 80 mg IV bolus, then 8 mg/h until\nendoscopy. If cirrhosis and acute variceal hemor\nrhage, transfuse platelet and FFP PRN, antibiotics\nfor 7 days (ceftriaxone 1 g IV q24h, cefotaxime 1 g\nIV q8h, ciprofloxacin 400 mg IV q12h, ciprofloxacin\n500 mg PO BID, or norfloxacin 400 mg PO BID).\nConsult GI for gastroscopy and consider erythro\nmycin 250 mg IV 30 90 min before endoscopy for\nclot lavage\nTREAT UNDERLYING CAUSE\navoid ASA, NSAIDs.\nPeptic ulcer (endoscopic hemostasis with thermal\ncoagulation/fibrin sealant/endoclips plus 1:10,000\nratio epinephrine injection. After endoscopy, start\npantoprazole 80 mg IV bolus if not given already,\nthen 8 mg/h \u000472 h [if high risk lesion], switch to\n40 mg PO BID \u00041 month then daily). Varices (endo\nscopy within 12 h with ligation/band/glue/sclerother\napy ! balloon tamponade ! TIPPS ! portacaval/\ndistal splenorenal shunt, or liver transplant. Continue\noctreotide for 3 5 days. Repeat endoscopy every\n2 weeks until varices obliterated, then at 1 3 months\nand again every 6 12 months afterward. Consider\nnon selective b blocker such as nadalol 40 mg PO\ndaily. Mallory Weiss tear (omeprazole 20 mg PO\ndaily). H. pylori (see DYSPEPSIA p. 113 for treatment).\nIntractable or recurrent bleed (consult surgery. See\nTREATMENT ISSUES below)\nTREATMENT ISSUES\nCRITERIA FOR SURGICAL CONSULT FOR ULCER\nBLEED\nhemodynamic\ninstability\ndespite\nSens\nSpc\nLR+\nLR\nTongue with furrows\n85%\n58%\n2.0\n0.3\nSunken eyes\n62%\n82%\n3.4\n0.5\nConfusion\n57%\n73%\n2.1\n0.6\nUpper/lower extremity weakness\n43%\n82%\n2.3\n0.7\nSpeech not clear or expressive\n56%\n82%\n3.1\n0.5\nCapillary refill time >normal\n34%\n95%\n6.9\n0.7\nAPPROACH\n\u2018\u2018for patients with suspected acute blood loss, severe postural dizziness (preventing upright\nvitals measurements) or postural pulse increment are predictive. Postural hypotension has no incremental\nvalue. For patients with suspected hypovolemia not due to blood loss, severe postural dizziness, postural\npulse increment, or dry axilla can be helpful. Moist mucous membranes and tongue without furrows argue\nagainst it. Capillary refill time and poor skin turgor have no proven diagnostic value\u2019\u2019\nJAMA 1999 281:11\nCLINICAL FEATURES (CONT\u2019D)\nUpper GI Bleed\n119", "text_length": 4197, "metadata": {"source": "Approach to Internal Medicine_ A Resource Book for Clinical Practice ( PDFDrive ).pdf (Part 131/464)", "type": "chunk", "chunk_index": 130, "total_chunks": 464, "uploaded_by": "admin@admin.com", "upload_date": "2025-12-11T18:40:09.424819", "document_uuid": "fda2cab4-cdd9-4015-af24-46fd62c86d94", "filename": "Approach to Internal Medicine_ A Resource Book for Clinical Practice ( PDFDrive ).pdf", "category": "medical_pdf", "section": "body", "year": null, "outdated": false, "document_id": "fda2cab4-cdd9-4015-af24-46fd62c86d94"}, "created_at": "2025-12-11T18:40:09.425567", "status": "complete", "chunks_added": 3}